9QX — Beverly JCG Share Price
0.000.00%
Last trade - 00:00- SG$6.48m
- SG$9.06m
- SG$8.04m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 48.76 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 18.37 | ||
| Price to Sales | 0.81 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -166.62% | ||
| Return on Equity | n/a | ||
| Operating Margin | -27.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 3.18 | 5.45 | 8.97 | 10.51 | 8.04 | n/a | n/a | 37.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Beverly JCG Ltd. is a Singapore-based company, which is engaged in the investment holding and provision of management services. The Company operates through three segments: aesthetic medical and healthcare, trading and distribution, and investment and others. The aesthetic medical and healthcare segment is engaged in the provision of aesthetic medical services, including the provision of aesthetic medical, beauty and wellness services. The trading and distribution segment is engaged in trading and distribution of steel raw materials, instruments and semi-finished products for steel mills, iron and steel foundries and aluminum smelters in the Asia-Pacific region and provision of ancillary services. The investment and others segment is engaged in the business of investment holding, provision of management services and provision of marketing, distribution and related services. Its subsidiaries include Albedo Corporation Pte. Ltd. and Beverly Wilshire Medical Centre (JB) Sdn. Bhd.
Directors
- Tian Sang Ng CHM (74)
- How Er Ng DCE (41)
- Sin Yuen Seah CFO (39)
- Beng Hong Ong SEC
- Swee Gek Tan SEC
- Wai Man Cheung IND (41)
- Lee Lam IND (62)
- Siean Sin Yap NID (57)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 18th, 2005
- Public Since
- April 13th, 2006
- No. of Employees
- 122
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 589,532,745
- Address
- 160 Robinson Road, #05-08 SBF Centre, 068914
- Web
- https://www.beverlyjcg.com/
- Phone
- +65 67087630
- Auditors
- RT LLP
Upcoming Events for 9QX
Q1 2024 Beverly JCG Ltd Earnings Release
Half Year 2024 Beverly JCG Ltd Earnings Release
Similar to 9QX
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Clearbridge Health
Singapore Exchange Securities Trading Ltd
FAQ
What is the Beverly JCG share price?
As of Today at 01:03 UTC, shares in Beverly JCG are trading at SG$0.01. This share price information is delayed by 15 minutes.
How has the Beverly JCG share price performed this year?
Shares in Beverly JCG last closed at SG$0.01 and the price had moved by -78% over the past 365 days. In terms of relative price strength the Beverly JCG share price has underperformed the FTSE Developed Asia Pacific Index by -77.98% over the past year.
What are the analyst and broker recommendations for Beverly JCG?
There is no consensus recommendation for this security.
What is the Beverly JCG dividend yield?
Beverly JCG does not currently pay a dividend.
Does Beverly JCG pay a dividend?
Beverly JCG does not currently pay a dividend.
When does Beverly JCG next pay dividends?
Beverly JCG does not currently pay a dividend.
How do I buy Beverly JCG shares?
To buy shares in Beverly JCG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Beverly JCG?
As of the previous close price of SG$0.01, shares in Beverly JCG had a market capitalisation of SG$6.48m.
Where are Beverly JCG shares listed?
Here are the trading details for Beverly JCG:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 9QX
What kind of share is Beverly JCG?
Based on an overall assessment of its quality, value and momentum Beverly JCG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Beverly JCG share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Beverly JCG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Beverly JCG. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -80.21%.
As of the last closing price of SG$0.01, shares in Beverly JCG were trading -71.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Beverly JCG PE Ratio?
The Beverly JCG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Beverly JCG?
Beverly JCG's management team is headed by:
- Tian Sang Ng - CHM
- How Er Ng - DCE
- Sin Yuen Seah - CFO
- Beng Hong Ong - SEC
- Swee Gek Tan - SEC
- Wai Man Cheung - IND
- Lee Lam - IND
- Siean Sin Yap - NID